Previous 10 | Next 10 |
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain PR Newswire BOSTON , April 10, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DN...
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks PR Newswire Ginkgo epidemiological modeling experts and Northeastern University researchers awarded new grant from the Bill & Melinda Gates Foundation BOSTON , April 10, 202...
2024-04-08 09:00:00 ET Artificial intelligence (AI) is quickly becoming a competitive differentiator for biopharma companies. While there's no clear victor yet, there are a few businesses that have built AI into the center of their strategy. To get an idea about how big of an impact AI ...
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufac...
2024-04-05 14:32:16 ET More on Markets AllianceBernstein spotlights demand shifts in the EV industry We're seeing new money come into Bitcoin – TD Securities Treasury yields continue to climb, see what SA analysts have to say AllianceBernstein warns of...
Ginkgo Bioworks to Host 5th Annual Ferment Conference PR Newswire BOSTON , April 4, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its annual conference, Ferment , on Thu...
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing PR Newswire The partnership combines Ginkgo's AI/ML and enzyme engineering expertise with Prozomix's wealth of enzyme sequence data to create best-in-class enzymes fo...
2024-04-03 04:19:00 ET Investors looking for stocks that can produce dramatic gains over the next 12 months want to turn their attention to the biotechnology industry. Wall Street analysts tasked with following a synthetic biology company called Ginkgo Bioworks (NYSE: DNA) think it ...
2024-04-02 07:30:19 ET Read the full article on Seeking Alpha For further details see: Ginkgo Bioworks acquires cell therapy assets from Modulus Therapeutics
Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs PR Newswire BOSTON , April 2, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurit...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation PR Newswire Presentation and Q&A session scheduled for post-market on Thursday, May 9, 2024 BOSTON , May 2, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "...
2024-04-30 10:00:00 ET In a world where biotechnology is always becoming more sophisticated, manufacturing-oriented biotech businesses like Ginkgo Bioworks (NYSE: DNA) are upping the ante by becoming larger and more capable of handling complex asks from customers. But doing that req...
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...